optical coherence tomography

optical coherence tomography
Name	Optical coherence tomography
Type	Imaging
Invented	1990s

optical coherence tomography

Optical coherence tomography (OCT) is an interferometric imaging modality that produces cross-sectional and volumetric images of scattering tissues using near-infrared light. OCT has become essential in ophthalmology, dermatology, cardiology, and neuroscience, with commercial systems developed by companies and institutions such as Zeiss, Optovue, Nidek, Topcon Corporation, and research groups at Massachusetts Institute of Technology, Harvard University, and Stanford University. The technique builds on concepts from interferometry and signal processing pioneered in laboratories associated with Bell Labs and MIT Lincoln Laboratory.

History

The origins of OCT trace to early interferometry experiments at Bell Labs and ultrasonography work at University of California, San Francisco during the late 20th century, with foundational demonstrations in the 1990s by groups at Massachusetts General Hospital, Wellman Center for Photomedicine, and researchers affiliated with Harvard Medical School, New York University, and University College London. Commercialization accelerated through partnerships involving Carl Zeiss Meditec, Topcon Corporation, Optovue, and translational efforts supported by grants from agencies such as the National Institutes of Health, the Wellcome Trust, and the European Commission. Major milestones include the transition from time-domain to spectral-domain techniques and the introduction of swept-source systems, developments documented alongside advances in optical fiber technology from Corning Incorporated and laser sources produced by firms like Fujitsu and Santec.

Principles and Technology

OCT operates on low-coherence interferometry using broadband or swept laser sources developed by companies such as NKT Photonics and Thorlabs, combining principles from experiments at Bell Labs and theory from researchers linked to Stanford University and Caltech. The method compares backscattered light from tissue against a reference arm using beam splitters produced by manufacturers like 3M Company and detectors manufactured by Hamamatsu Photonics, with signal processing algorithms inspired by work at Massachusetts Institute of Technology and Carnegie Mellon University. System architectures include time-domain, spectral-domain, and swept-source designs, each relying on components from Intel Corporation and Broadcom Inc. for data acquisition and digital signal processors developed by Texas Instruments and Analog Devices. Image reconstruction uses Fourier transforms and dispersion compensation techniques refined in collaborations involving University of California, Berkeley and Imperial College London.

Clinical Applications

In ophthalmology, OCT is routinely used in management protocols at institutions like Moorfields Eye Hospital, Bascom Palmer Eye Institute, and Wilmer Eye Institute for diagnosing conditions including age-related macular degeneration, diabetic macular edema, and glaucoma, with guidelines referenced by societies such as the American Academy of Ophthalmology and the Royal College of Ophthalmologists. Cardiology applications involve intravascular OCT catheters developed with partners including Boston Scientific, Abbott Laboratories, and Terumo Corporation for stent evaluation in clinical trials run at centers like Cleveland Clinic and Mayo Clinic. Dermatology, oncology, and neurology centers at Johns Hopkins University, Dana-Farber Cancer Institute, and University of Pittsburgh Medical Center apply OCT for lesion assessment, margin delineation, and research into neurodegenerative diseases supported by organizations such as the Alzheimer's Association.

Image Interpretation and Metrics

OCT image interpretation relies on standardized metrics and segmentation algorithms developed through consortia including the International Council of Ophthalmology and datasets curated by groups at Duke University, King's College London, and University of Toronto. Quantitative measures include retinal nerve fiber layer thickness and macular volume, used in studies from Moorfields Eye Hospital and regulatory submissions to agencies such as the Food and Drug Administration and the European Medicines Agency. Automated analysis often leverages machine learning frameworks originating from research at Google DeepMind, IBM Research, and Microsoft Research, with validation cohorts collected at centers like Massachusetts Eye and Ear and University College London Hospitals.

Limitations and Risks

Limitations of OCT include shallow penetration depth in highly scattering tissues, motion artifacts in procedures at interventional centers like Cleveland Clinic, and interpretation variability noted in multicenter studies coordinated by the World Health Organization and professional societies such as the American Academy of Ophthalmology. Risks in intravascular or intraoperative use involve catheter complications reported in trials at Mayo Clinic and device registries overseen by bodies like the U.S. Food and Drug Administration. Regulatory, reimbursement, and training challenges have been addressed in policy discussions involving the Centers for Medicare & Medicaid Services, National Health Service (England), and professional organizations including the European Society of Cardiology.

Research and Future Developments

Active research programs at institutions including Massachusetts Institute of Technology, Harvard Medical School, Stanford University, University of Cambridge, and ETH Zurich pursue higher-speed sources from firms like Keyence Corporation and integrated photonics from companies such as Intel Corporation. Emerging directions encompass multimodal imaging combining OCT with fluorescence and photoacoustic modalities investigated at Johns Hopkins University and California Institute of Technology, AI-driven image interpretation from teams at DeepMind and Stanford AI Lab, and translation into portable devices supported by startups incubated at Y Combinator and technology transfer offices at MIT Technology Licensing Office.

Category:Medical imaging